Market Cap (In AUD)
239.7 Million
Revenue (In AUD)
63.35 Million
Net Income (In AUD)
-9.74 Million
Avg. Volume
692.74 Thousand
- Currency
- AUD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.44-0.87
- PE
- -
- EPS
- -
- Beta Value
- 0.62
- ISIN
- NZARXE0001S1
- CUSIP
- Q05263100
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Dr. Brian Ward B.V.Sc, MBA(dist)
- Employee Count
- -
- Website
- https://aroabio.com
- Ipo Date
- 2020-07-24
- Details
- Aroa Biosurgery Limited, a regenerative medicine company, engages in the developing, manufacturing, and distributing medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. The company's products include Endoform Natural and Endoform Antimicrobia Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; and Reinforced Bioscaffolds, a surgical product for use in ventral hernia repair and abdominal wall reconstruction. Aroa Biosurgery Limited was incorporated in 2007 and is headquartered in Auckland, New Zealand.
More Stocks
-
NVDANVIDIA Corporation
NVDA
-
OZYSR
-
LINLinde plc
LIN
-
DIIBFDorel Industries Inc.
DIIBF
-
TALN
-
EPIAFEpiroc AB (publ)
EPIAF
-
MDI
-
1073